CM-301

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCM-301
Drug Alias NameCM-301
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionC-C motif chemokine 5 inhibitorsEotaxin inhibitorsC-C chemokine receptor type 3 antagonists
TargetsC-C motif chemokine 5C-C chemokine receptor type 3Eotaxin
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemomab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChemomab
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A